Cytokinetics, Incorporated Development Agreements
13 Contracts & Agreements
- guidance concerning revenues, research and development expenses and general and administrative expenses for 2011 (Filed With SEC on March 11, 2011)
- guidance concerning revenues, research and development expenses and general and administrative expenses for 2011 (Filed With SEC on March 11, 2011)
- guidance concerning revenues, research and development expenses and general and administrative expenses for 2010 (Filed With SEC on March 11, 2010)
- guidance concerning revenues, research and development expenses and general and administrative expenses for 2009 (Filed With SEC on March 12, 2009)
- guidance concerning revenues, research and development expenses and general and administrative expenses for 2009 (Filed With SEC on March 12, 2009)
- guidance concerning revenues, research and development expenses and general and administrative expenses for 2009 (Filed With SEC on March 12, 2009)
- guidance concerning revenues, research and development expenses and general and administrative expenses for 2009 (Filed With SEC on March 12, 2009)
- guidance concerning revenues, research and development expenses and general and administrative expenses for 2009 (Filed With SEC on March 12, 2009)
- guidance concerning revenues, research and development expenses and general and administrative expenses for 2009 (Filed With SEC on March 12, 2009)
- guidance concerning revenues, research and development expenses and general and administrative expenses for 2009 (Filed With SEC on March 12, 2009)
- guidance concerning revenues, research and development expenses and general and administrative expenses for 2009 (Filed With SEC on March 12, 2009)
- the initiation, progress, timing, scope and anticipated date of completion of clinical trials and development for our drug candidates and potential drug candidates by ourselves,... (Filed With SEC on March 12, 2007)
- the initiation, progress, timing, scope and anticipated date of completion of preclinical research, clinical trials and development for our drug candidates and potential drug... (Filed With SEC on March 10, 2006)
